Duta Pertiwi Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Duta Pertiwi Tbk trades at Rp4,090 (market cap 7.57T, 3.1K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp244 (market cap 167.37B, 79.7K 24h volume). The key difference: Duta Pertiwi Tbk is far larger — about 45.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (79.7K versus 3.1K). Which is the better fit depends on your goals.
| DUTI | OBAT | |
|---|---|---|
Market Cap | 7.57T | 167.37B |
Volume | 3.1K | 79.7K |
Lot | 31 | 797 |
Turnover | 12.68M | 19.62M |
Average Price | 4,090 | 246.19 |
Value | 12.68M | 19.62M |
Indicative Equilibrium Price | 4,080 | 246 |
Indicative Equilibrium Volume | 50 | 2.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Duta Pertiwi Tbk (the Company) was established based on Notarial Deed No. 237 dated December 29, 1972 of Mohamad Said Tadjoedin, S.H., a public notary in Jakarta. The Company operates and engaged in commercial mixed use development (i.e. shophouse, kiosk/small retail space, strata office space) as well as housing, shopping center, apartment, and hotel developments.
Read more on DUTI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →